Arkolith/Insider Trading/ORKA/Form 4

Goncalves Joana

Chief Medical OfficerOruka Therapeutics, Inc. (ORKA) · full profile →Form 4 · filed Mar 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$313K
Net Open-Market Flow
-$313K
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Sell(S)1K$41.94$49K34K
Mar 16, 2026Sell(S)3K$41.20$120K35K
Mar 16, 2026Sell(S)3K$40.11$117K38K
Mar 16, 2026Option exercise(M)4K$7.80$27K41K
Mar 16, 2026Option exercise(M)4K$6.84$24K38K
Mar 16, 2026Sell(S)641$41.30$26K33K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 16, 2026Option exercise(M)4K—$0186K
Mar 16, 2026Option exercise(M)4K—$0215K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000030) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML